Hyaluronic acid: a specific prognostic indicator of hepatic damage in biliary atresia

J Pediatr Surg. 1999 Dec;34(12):1791-4. doi: 10.1016/s0022-3468(99)90314-7.

Abstract

Background/purpose: Hepatic fibrosis can progress in biliary atresia (BA) and is associated with capillarization of hepatic sinusoids. The significance of serum hyaluronic acid (HA) as a noninvasive indicator of histological sinusoidal endothelial cell (SEC) damage and hepatic fibrosis in BA, is investigated.

Methods: A total of 28 postoperative BA patients (mean age, 11.0+/-3.7 years) and 20 normal controls (mean age, 10.5+/-2.8 years) were studied. BA patients were divided into group I, good liver function (n = 8); group II, moderate liver dysfunction (n = 10); and group III, severe liver dysfunction (n = 10). Serum HA was determined using a one-step sandwich enzyme immunoassay, and liver histological damage was confirmed immunohistochemically using an antibody against factor VIII-related antigen (FVIIIRAg), which is specific for detecting damaged SEC.

Results: Serum HA was significantly higher (P < .0001) in group III (84.6+/-36.5 ng/mL) than in group I (15.9+/-6.9 ng/mL) or group 11 (28.7+/-10.7 ng/mL). Although immunoreactive products of FVIIIRAg were abundant in group III, they were not detected in SEC from group II.

Conclusion: Serum HA may be of value for monitoring postoperative BA patients as a noninvasive indicator of SEC damage and progressive hepatic fibrosis.

MeSH terms

  • Adolescent
  • Biliary Atresia / pathology*
  • Biomarkers
  • Child
  • Humans
  • Hyaluronic Acid / blood*
  • Immunohistochemistry
  • Liver / pathology*
  • Liver Cirrhosis / pathology*
  • von Willebrand Factor / analysis

Substances

  • Biomarkers
  • von Willebrand Factor
  • Hyaluronic Acid